Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 180.00
Bid: 175.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 10.00 (5.714%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 180.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Advantage DCP Limited

15 Nov 2018 07:00

RNS Number : 4100H
Helios Underwriting Plc
15 November 2018
 

Helios Underwriting plc

("Helios" or the "Company")

Acquisition of Advantage DCP Limited

Helios is pleased to announce that, in line with its strategy of increasing underwriting capacity through acquisition, it has acquired Advantage DCP Limited ("Advantage"), a limited liability member of Lloyd's of London ("Lloyd's") subject to consent for change of control from Lloyd's (the "Acquisition"). The consideration for Advantage is between £1.66 million and £1.91 million, dependent on no deterioration from the current 2017 year of account midpoint forecast of Advantage and the final result of that year. The consideration, which is in cash, will be payable as to £450,000 at completion with the balance paid in tranches in 2019 and 2020.

Information in respect of Advantage

The 2018 underwriting capacity of Advantage is £2.3m (this compares with Helios's 2018 capacity of £43.0m prior to this acquisition).

The maximum consideration represents a discount of 27% to the independent valuation of £2.6m placed on Advantage by Humphrey's and approximately £0.6m below the fair value of assets being acquired.

The capacity acquired, together with the capacity Helios expects to retain, is as follows:

Advantage

Year of Account

 

2016

2017

2018

 

£m

£m

£m

Retained

3.6

3.1

2.3

Reinsured

-

-

-

Total Capacity

3.6

3.1

2.3

 

In addition to the Advantage transaction, Helios is continuing to pursue a number of further Lloyd's LLV acquisitions in line with its strategy.

Additional information

Advantage is a limited liability member of Lloyd's. In the year ended 31 December 2017, Advantage made a loss before tax of £0.2m on gross premiums written of £4.3m. Underwriting capacity with an estimated market value of £0.2m has been included in the transaction.

 

For further information, please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive 020 7863 6655 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

Stockdale Securities Limited

Robert Finlay 020 7601 6100

David Coaten

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £45m of capacity for the 2018 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQDDBDBBDBBGIS
Date   Source Headline
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings
2nd Oct 20237:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.